DMAC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.30%

Insider Buying (Last 12 Months): $11,358,597.89

Insider Selling (Last 12 Months): $0.00

DiaMedica Therapeutics Insider Trading History Chart

DiaMedica Therapeutics Share Price & Price History

^$8.63

▲ +0.12 (1.41%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

DiaMedica Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/27/2025	Jan Stahlberg	Major Shareholder	Buy	50,772	$6.00	$304,632.00	7,764,465
8/26/2025	Jan Stahlberg	Major Shareholder	Buy	59,648	$6.00	$357,888.00	7,713,693
8/25/2025	Jan Stahlberg	Major Shareholder	Buy	338,265	$6.00	$2,029,590.00	7,654,045
8/22/2025	Jan Stahlberg	Major Shareholder	Buy	59,788	$5.96	$356,336.48	7,315,780
8/21/2025	Jan Stahlberg	Major Shareholder	Buy	48,172	$5.96	$287,105.12	7,255,992
8/20/2025	Jan Stahlberg	Major Shareholder	Buy	71,107	$5.86	$416,687.02	7,207,820
8/15/2025	Jan Stahlberg	Major Shareholder	Buy	8,233	$6.00	$49,398.00	7,136,713
8/14/2025	Jan Stahlberg	Major Shareholder	Buy	70,414	$5.99	$421,779.86	7,128,480
8/13/2025	Jan Stahlberg	Major Shareholder	Buy	293,601	$5.91	$1,735,181.91	7,058,066
7/23/2025	Jan Stahlberg	Major Shareholder	Buy	1,542,857	$3.50	$5,399,999.50	6,764,465
6/28/2024	Koch Thomas Von	Major Shareholder	Buy	1,200,000	$2.50	$3,000,000.00	5,526,435
6/23/2023	David J Wambeke	Insider	Buy	38,364	$3.91	$150,003.24	507,114
6/23/2023	Dietrich John Pauls	CEO	Buy	12,787	$3.91	$49,997.17	68,591
6/23/2023	Koch Thomas Von	Major Shareholder	Buy	1,470,588	$3.40	$4,999,999.20	4,326,435
6/23/2023	Randall Michael Giuffre	Director	Buy	65,000	$3.91	$254,150.00	360,355
6/23/2023	Scott Kellen	CFO	Buy	10,000	$3.91	$39,100.00	32,290
4/10/2023	David J Wambeke	Insider	Buy	468,750	$1.60	$750,000.00	468,750
12/8/2022	Randall Michael Giuffre	Director	Buy	20,000	$1.40	$28,000.00	223,146
12/6/2022	Randall Michael Giuffre	Director	Buy	2,300	$1.35	$3,105.00	180,572

SEC Filings (Institutional Ownership Changes) for DiaMedica Therapeutics (NASDAQ:DMAC)

10.12% of DiaMedica Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

DiaMedica Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/1/2025	Cantor Fitzgerald L. P.	100,000	$0.69M	0.0%	N/A	0.192%
11/17/2025	Private Capital Management LLC	50,000	$0.34M	0.0%	N/A	0.096%
11/17/2025	Qube Research & Technologies Ltd	39,549	$0.27M	0.0%	N/A	0.076%
11/17/2025	Millennium Management LLC	1,187,309	$8.16M	0.0%	N/A	2.280%
11/17/2025	Citadel Advisors LLC	69,352	$0.48M	0.0%	N/A	0.133%
11/17/2025	Cooperman Leon G	3,269,761	$22.46M	0.7%	+98.2%	6.279%
11/17/2025	Bank of America Corp DE	12,249	$84K	0.0%	+44.2%	0.024%
11/17/2025	Cantor Fitzgerald L. P.	100,000	$0.69M	0.0%	N/A	0.192%
11/14/2025	Creative Planning	38,790	$0.27M	0.0%	N/A	0.075%
11/14/2025	Raymond James Financial Inc.	36,501	$0.25M	0.0%	+131.5%	0.071%
11/14/2025	Man Group plc	19,414	$0.13M	0.0%	N/A	0.038%
11/13/2025	BNP Paribas Financial Markets	7,432	$51K	0.0%	-60.6%	0.014%
11/13/2025	Russell Investments Group Ltd.	3,921	$27K	0.0%	N/A	0.008%
11/13/2025	Paragon Associates & Paragon Associates II Joint Venture	875,000	$6.01M	10.7%	+34.6%	1.693%
11/12/2025	Corient IA LLC	132,500	$0.91M	0.7%	N/A	0.256%
11/7/2025	Vanguard Group Inc.	664,575	$4.57M	0.0%	-56.7%	1.286%
11/6/2025	Rhumbline Advisers	27,357	$0.19M	0.0%	+14.5%	0.053%
11/4/2025	Meridian Wealth Management LLC	51,666	$0.36M	0.0%	+89.1%	0.100%
11/3/2025	New York State Common Retirement Fund	11,800	$81K	0.0%	-55.1%	0.023%
10/30/2025	Strs Ohio	9,100	$63K	0.0%	+19.7%	0.018%
10/15/2025	World Investment Advisors	34,325	$0.24M	0.0%	+7.3%	0.066%
9/4/2025	Osaic Holdings Inc.	144,290	$0.56M	0.0%	+374.7%	0.279%
8/15/2025	BNP Paribas Financial Markets	18,882	$74K	0.0%	+24.4%	0.037%
8/15/2025	Bank of America Corp DE	8,497	$33K	0.0%	+3,710.3%	0.016%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	14,425	$56K	0.0%	N/A	0.028%
8/13/2025	Marshall Wace LLP	61,719	$0.24M	0.0%	+227.8%	0.119%
8/13/2025	Invesco Ltd.	13,885	$54K	0.0%	N/A	0.027%
8/13/2025	New York State Common Retirement Fund	26,300	$0.10M	0.0%	N/A	0.051%
8/12/2025	JPMorgan Chase & Co.	12,483	$49K	0.0%	N/A	0.024%
8/8/2025	Intech Investment Management LLC	14,415	$56K	0.0%	N/A	0.028%
8/8/2025	Police & Firemen s Retirement System of New Jersey	7,441	$29K	0.0%	N/A	0.014%
8/8/2025	Geode Capital Management LLC	630,148	$2.46M	0.0%	+99.6%	1.219%
8/4/2025	World Investment Advisors	31,975	$0.13M	0.0%	+24.7%	0.075%
7/16/2025	Perigon Wealth Management LLC	53,000	$0.21M	0.0%	N/A	0.124%
6/27/2025	Goldman Sachs Group Inc.	121,802	$0.46M	0.0%	+76.7%	0.284%
5/19/2025	Jane Street Group LLC	100,669	$0.38M	0.0%	+138.5%	0.235%
5/16/2025	Goldman Sachs Group Inc.	121,802	$0.46M	0.0%	+76.7%	0.284%
5/15/2025	First Manhattan CO. LLC.	606,435	$2.30M	0.0%	-27.7%	1.415%
5/15/2025	Royal Bank of Canada	155,031	$0.59M	0.0%	+46,879.1%	0.362%
4/29/2025	World Investment Advisors	25,650	$97K	0.0%	+17.0%	0.060%
4/18/2025	Cornerstone Wealth Management LLC	16,250	$62K	0.0%	N/A	0.038%
2/17/2025	OMERS ADMINISTRATION Corp	22,500	$0.12M	0.0%	N/A	0.053%
2/17/2025	Millennium Management LLC	84,829	$0.46M	0.0%	+151.8%	0.198%
2/17/2025	Balyasny Asset Management L.P.	14,581	$79K	0.0%	N/A	0.034%
2/17/2025	683 Capital Management LLC	76,116	$0.41M	0.0%	N/A	0.178%
2/14/2025	Jane Street Group LLC	42,212	$0.23M	0.0%	N/A	0.099%
2/14/2025	Schonfeld Strategic Advisors LLC	26,097	$0.14M	0.0%	N/A	0.061%
2/14/2025	Northern Trust Corp	180,192	$0.98M	0.0%	+49.8%	0.421%
2/14/2025	Susquehanna International Group LLP	374,845	$2.04M	0.0%	+269.5%	0.877%
2/14/2025	Dimensional Fund Advisors LP	19,339	$0.11M	0.0%	+14.0%	0.045%
2/13/2025	Barclays PLC	27,726	$0.15M	0.0%	N/A	0.065%
2/13/2025	Raymond James Financial Inc.	15,267	$83K	0.0%	N/A	0.036%
2/13/2025	Bank of Montreal Can	15,560	$84K	0.0%	N/A	0.036%
2/12/2025	World Investment Advisors	21,915	$0.12M	0.0%	N/A	0.051%
2/12/2025	Paragon Associates & Paragon Associates II Joint Venture	514,784	$2.80M	6.5%	+6.7%	1.204%
2/11/2025	LPL Financial LLC	152,000	$0.83M	0.0%	+8.2%	0.355%
2/6/2025	Raymond James Financial Inc.	15,267	$83K	0.0%	N/A	0.036%
2/6/2025	Meridian Wealth Management LLC	27,216	$0.15M	0.0%	N/A	0.064%
2/4/2025	Y Intercept Hong Kong Ltd	14,973	$81K	0.0%	N/A	0.035%
1/30/2025	Blue Trust Inc.	69,122	$0.38M	0.0%	+56.2%	0.162%
1/22/2025	Blue Trust Inc.	69,122	$0.38M	0.0%	+56.2%	0.162%
11/16/2024	Geode Capital Management LLC	306,958	$1.29M	0.0%	+29.6%	0.718%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	9,498	$40K	0.0%	N/A	0.022%
10/18/2024	Blue Trust Inc.	44,247	$0.19M	0.0%	N/A	0.104%
8/16/2024	Magnolia Capital Advisors LLC	29,500	$87K	0.0%	N/A	0.069%
5/10/2024	Vanguard Group Inc.	1,013,522	$2.81M	0.0%	+26.3%	2.670%
2/15/2024	Paragon Associates & Paragon Associates II Joint Venture	500,000	$1.42M	3.3%	+6.4%	1.318%
2/7/2024	Avantax Advisory Services Inc.	12,500	$36K	0.0%	N/A	0.033%
11/15/2023	Stonebridge Capital Advisors LLC	20,000	$52K	0.0%	N/A	0.053%
11/13/2023	EAM Investors LLC	212,512	$0.55M	0.1%	-21.4%	0.560%
11/9/2023	Bleichroeder LP	222,317	$0.57M	0.1%	-24.4%	0.586%
11/1/2023	Jacob Asset Management of New York LLC	168,730	$0.44M	0.6%	-15.1%	0.445%
8/30/2023	Cooperman Leon G	875,993	$3.78M	0.2%	+0.9%	2.308%
8/10/2023	Jacob Asset Management of New York LLC	198,730	$0.86M	1.0%	-15.0%	0.738%
8/2/2023	Catalyst Financial Partners LLC	36,267	$0.16M	0.1%	+44.4%	0.135%
4/11/2023	Catalyst Financial Partners LLC	25,110	$38K	0.0%	+73.5%	0.095%
5/12/2022	Jacob Asset Management of New York LLC	265,000	$0.66M	0.4%	-3.6%	1.002%
2/15/2022	Stonepine Capital Management LLC	1,194,670	$4.46M	2.0%	+620.7%	4.519%
11/15/2021	Marshall Wace LLP	10,031	$40K	0.0%	-93.6%	0.053%
11/15/2021	Manatuck Hill Partners LLC	273,100	$1.10M	0.4%	-52.1%	1.454%
11/12/2021	Stonepine Capital Management LLC	165,775	$0.67M	0.3%	-60.5%	0.882%
11/12/2021	Jump Financial LLC	18,300	$73K	0.0%	N/A	0.097%
11/9/2021	BlackRock Inc.	55,970	$0.23M	0.0%	-8.6%	0.298%
8/16/2021	State Street Corp	30,217	$0.13M	0.0%	N/A	0.161%

Data available starting January 2016

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase II/III trials for the treatment of acute ischemic stroke, as well as that is in Phase 2 to treat cardio-renal disease. The company also develops DM300, which is in preclinical stage for the treatment of severe inflammatory diseases. In addition, it develops treatment for neurological disease. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Today's Range

Now: $8.63

$7.97

$8.88

50 Day Range

MA: $7.08

$5.42

$9.12

52 Week Range

Now: $8.63

$3.19

$9.23

Volume

335,609 shs

Average Volume

520,772 shs

Market Capitalization

$449.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

Who are the company insiders with the largest holdings of DiaMedica Therapeutics?: DiaMedica Therapeutics' top insider shareholders include:
Jan Stahlberg (Major Shareholder)
Koch Thomas Von (Major Shareholder)
Learn More about top insider investors at DiaMedica Therapeutics.
Who are the major institutional investors of DiaMedica Therapeutics?: DiaMedica Therapeutics' top institutional investors include:
Cooperman Leon G — 6.28%
Millennium Management LLC — 2.28%
Paragon Associates & Paragon Associates II Joint Venture — 1.69%
Vanguard Group Inc. — 1.29%
Corient IA LLC — 0.26%
Cantor Fitzgerald L. P. — 0.19%
Learn More about top institutional investors of DiaMedica Therapeutics stock.
Which institutional investors are selling DiaMedica Therapeutics stock?: During the last quarter, DMAC stock was sold by these institutional investors:
Vanguard Group Inc.
New York State Common Retirement Fund
BNP Paribas Financial Markets
Which institutional investors are buying DiaMedica Therapeutics stock?: In the previous quarter, DMAC stock was purchased by institutional investors including:
Cooperman Leon G
Millennium Management LLC
Paragon Associates & Paragon Associates II Joint Venture
Corient IA LLC
Cantor Fitzgerald L. P.
Cantor Fitzgerald L. P.
Citadel Advisors LLC
Private Capital Management LLC
Within the previous year, these company insiders have bought DiaMedica Therapeutics stock:
Jan Stahlberg (Major Shareholder)
Koch Thomas Von (Major Shareholder)
Learn More investors buying DiaMedica Therapeutics stock.